Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab

Growing evidence indicates that the affinity of monoclonal antibodies (mAbs) for CD16 (FcγRIII) plays a central role in the ability of the mAb to mediate antitumor activity. We evaluated how CD16 polymorphisms, and mAb with modified affinity for target antigen and CD16, affect natural killer (NK) ce...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Bowles, Julie A., Wang, Siao-Yi, Link, Brian K., Allan, Barrett, Beuerlein, Gregory, Campbell, Mary-Ann, Marquis, David, Ondek, Brian, Wooldridge, James E., Smith, Brian J., Breitmeyer, James B., Weiner, George J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: © 2006 by The American Society of Hematology 2006
Konular:
Immunobiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1895597/
https://ncbi.nlm.nih.gov/pubmed/16825493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-04-020057
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller